Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpiCept NP-1 in Pain from Diabetic Peripheral Neuropathy
NCT00476151Phase 2Completed
- Sponsor
- EpiCept Corporation
- Start
- Jul 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amitriptyline + Ketamine in diabetic peripheral neuropathy (DPN), sponsored by EpiCept Corporation. Started Jul 2007; status: completed.
02
Drugs
Amitriptyline + Ketamine
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00476151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476151.